rasagiline: Clinical Trials

19 trials of rasagiline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 unknown, 3 terminated, 1 withdrawn. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Completed 11, Unknown 4, Terminated 3, Withdrawn 1

Follow rasagiline: new trials by email Literature Review of rasagiline trials Research Report on rasagiline

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography
computerized dynamic posturography, Rasagiline 1 mg capsule, Placebo - PARKINSON DISEASE (Disorder)
Phase 4WithdrawnNew York Medical College2014-09-152025-07-24
Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study
AZILECT®, Placebo - Drug-naïve Patients With Parkinson's Disease, Apathy
Phase 4UnknownUniversity Hospital, Clermont-Ferrand502013-06-012013-01-10
Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Rasagiline, Placebo - Parkinson's Disease
Phase 4CompletedTeva Branded Pharmaceutical Products R&D, Inc.1702012-11-012021-11-09
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
Rasagiline/Placebo, Rasagiline - Parkinson's Disease
Phase 4CompletedGeorgetown University342012-01-012015-12-16
Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease
Rasagiline, Placebo - Sleep Disturbances, Parkinsons's Disease
Phase 4CompletedTechnische Universität Dresden302011-10-012016-01-21
Emotion, Mood and Executive Function in Parkinson's Disease (PD)
Rasagiline, Placebo - Parkinson Disease
Phase 4UnknownSt. Josef Hospital Bochum702011-10-012011-06-30
Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease
Rasagiline - Parkinson's Disease
Phase 4TerminatedUniversity of Zurich12011-09-012012-10-04
The Effect of Rasagiline on Cognition in Parkinson's Disease
Rasagiline, Placebo - Parkinson's Disease
Phase 4CompletedBrown University502011-06-012015-02-05
Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
Rasagiline, Placebo - Retinal Detachment
Phase 4TerminatedInsel Gruppe AG, University Hospital Bern232010-09-012019-02-20
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Rasagiline, Placebo - Depressive Symptoms, Parkinson's Disease
Phase 4CompletedLundbeck Italia S.p.A.1212010-03-012021-08-31
Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease
Rasagiline, Placebo - Parkinson's Disease
Phase 4CompletedUniversity of Florida302009-12-012014-01-10
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Rasagiline, Placebo - Parkinson's Disease
Phase 4CompletedTeva Neuroscience, Inc.3282009-12-012016-05-20
A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients
Rasagiline, Placebo - Parkinson's Disease
Phase 4UnknownThe Parkinson's Institute362009-11-012013-12-02
Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline
Azilect 1mg, Placebo - Parkinson´s Disease
Phase 4CompletedTechnische Universität Dresden342009-05-012012-02-07
Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease
Rasagiline, Pramipexole - Early-stage Parkinson's Disease
Phase 4TerminatedQualissima1122008-10-012012-05-28
Rasagiline and Apathy in Parkinson's Disease
Rasagiline - Parkinson's Disease
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau402008-09-012015-08-10
The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease
placebo, rasagiline - Parkinson's Disease
Phase 4UnknownIstanbul University402007-06-012008-06-12
Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia
rasagiline (Pharmacodynamics), Placebo - Schizophrenia
Phase 4CompletedUniversity of Maryland, Baltimore842007-01-012019-09-25
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
rasagiline mesylate, Rasagiline mesylate plus Mirapex, Rasagiline mesylate with Levodopa - Parkinson's Disease
Phase 4CompletedTeva Neuroscience, Inc.2002006-10-012011-04-12

Conditions studied

Parkinson Disease (16)  ·  Anosmia (2)  ·  Lethargy (2)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Fatigue (1)  ·  Parasomnias (1)  ·  Retinal Detachment (1)  ·  Schizophrenia (1)  ·  Sleep Wake Disorders (1)

Sponsors

Technische Universität Dresden (2)  ·  Teva Neuroscience, Inc. (2)  ·  Brown University (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Georgetown University (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Istanbul University (1)  ·  Lundbeck Italia S.p.A. (1)  ·  New York Medical College (1)  ·  Qualissima (1)  ·  St. Josef Hospital Bochum (1)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (1)  ·  The Parkinson's Institute (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of Florida (1)

Countries

United States (7)  ·  Germany (3)  ·  Switzerland (2)  ·  France (1)  ·  Italy (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)

Top investigators

Alexander Storch, MD (1)  ·  Andreas Ebneter (1)  ·  Azhar Choudhry, M.D. (1)  ·  Christian Baumann, Assoc Prof, MD (1)  ·  Fernando L Pagan, MD (1)  ·  Grace S Liang, MD (1)  ·  Heinz Reichmann, MD, PhD (1)  ·  Irene A Malaty, MD (1)  ·  Jaime Kulisevsky, MD,PhD (1)  ·  Joseph Friedman, MD (1)  ·  Laura L. Frakey, Ph.D. (1)  ·  MerriKay Oleen-Burkey, PhD (1)

Results publications

PMID 25368372

NIH funding

2008 (1), 2009 (1)